| Achievements of the COVID-19 Turkey Platform in vaccine and drug development with an approach of “co-creation and succeeding together” | Hasan MANDAL | 3139–3149 |
| Turkey’s response to COVID-19 pandemic: strategy and key actions | Sabahattin AYDIN, Gülşen BARLAS, Harun ÖZTÜRK, Gülen PEHLİVANTÜRK | 3150–3156 |
| One and a half years into the COVID-19 pandemic - exit strategies and efficacy of SARSCoV-2 vaccines for holistic management and achieving global control | Eskild PETERSEN, Asma Al BALUSHI, Alimuddin ZUMLA, Deniz GÖKENGİN | 3157–3161 |
| Going back to normal, but how? Re-opening policies and the standards for a new normal | Levent AKIN | 3162–3167 |
| Managing life during the pandemic: communication strategies, mental health, and the ultimate toll of the COVID-19 | Yasemin KAHYA, Mehmet Hakan TÜRKÇAPAR, Tuğba ÇAPAR TAŞKESEN, Hatice IŞIK | 3168–3181 |
| Short-term impact of the Covid-19 pandemic on the global and Turkish economy | Aslı GÜNAY, Ömer AÇIKGÖZ | 3182–3193 |
| Global health emergencies during the pandemic and their solutions | İrfan ŞENCAN, Dilek BULUT, Canan AĞALAR, İsmail Hakkı ŞENCAN | 3194–3206 |
| Nonpharmaceutical interventions in Turkey and worldwide during COVID-19 pandemic | Rahmi KILIÇ, Nuran YILDIRIM, Mustafa Necmi İLHAN, Hakan TÜZÜN | 3207–3214 |
| Current infection prevention and control strategies of COVID-19 in hospitals | Mehmet DOĞANAY, Emine ALP, Gamze KALIN ÜNÜVAR | 3215–3220 |
| Pandemic hospitals and reorganizing emergency departments | Afsin Emre KAYIPMAZ, Ahmet DEMİRCAN | 3221–3228 |
| Evaluating the efficiency of public policy measures against COVID-19 | Rahmet GÜNER, İmran HASANOĞLU, Firdevs AKTAŞ | 3229–3237 |
| How efficient are facial masks against COVID-19? Evaluating the mask use of various communities one year into the pandemic | Figen ÇİZMECİ ŞENEL, Aslıhan CANDEVİR, Yeşim TAŞOVA, Cem ÜNGÖR | 3238–3245 |